tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

QURE Stock Latest News

Deere, Cisco dip after quarterly reports: Morning Buzz
The FlyDeere, Cisco dip after quarterly reports: Morning Buzz
2d ago
BP
DE
uniQure upgraded to Outperform from Neutral at Mizuho
PremiumThe Fly
uniQure upgraded to Outperform from Neutral at Mizuho
2d ago
QURE
Promising Outlook for uniQure’s AMT-130 in Huntington’s Disease with Strategic Advancements and Regulatory Alignment
PremiumRatings
Promising Outlook for uniQure’s AMT-130 in Huntington’s Disease with Strategic Advancements and Regulatory Alignment
16d ago
QURE
uniQure N.V. Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
uniQure N.V. Earnings Call: Progress Amid Challenges
17d ago
QURE
Biotech stocks rise following Prasad exit from FDA
PremiumThe Fly
Biotech stocks rise following Prasad exit from FDA
17d ago
BHVN
CAPR
uniQure’s Promising Gene Therapy Advances and Strong Financial Position Justify Buy Rating
PremiumRatingsuniQure’s Promising Gene Therapy Advances and Strong Financial Position Justify Buy Rating
17d ago
QURE
uniQure price target lowered to $47 from $58 at Cantor Fitzgerald
Premium
The Fly
uniQure price target lowered to $47 from $58 at Cantor Fitzgerald
17d ago
QURE
uniQure Reports Q2 2025 Progress and Financials
Premium
Company Announcements
uniQure Reports Q2 2025 Progress and Financials
17d ago
QURE
uniQure price target lowered to $35 from $38 at Chardan
PremiumThe Fly
uniQure price target lowered to $35 from $38 at Chardan
18d ago
QURE
Mizuho defends uniQure, says factors why it is down are ‘non-issues’
PremiumThe Fly
Mizuho defends uniQure, says factors why it is down are ‘non-issues’
18d ago
QURE
Mizuho defends uniQure, says factors why it is down are ‘non-issues’
PremiumThe Fly
Mizuho defends uniQure, says factors why it is down are ‘non-issues’
18d ago
QURE
uniQure’s Strategic Advancements and Regulatory Progress Lead to Buy Rating
PremiumRatings
uniQure’s Strategic Advancements and Regulatory Progress Lead to Buy Rating
18d ago
QURE
Positive Outlook for uniQure’s AMT-130 Program Amidst Upcoming 3-Year Data Release
PremiumRatingsPositive Outlook for uniQure’s AMT-130 Program Amidst Upcoming 3-Year Data Release
18d ago
QURE
uniQure Announces $200 Million Sales Agreement
Premium
Company Announcements
uniQure Announces $200 Million Sales Agreement
18d ago
8K
QURE
uniQure reports Q2 EPS (69c), consensus (76c)
Premium
The Fly
uniQure reports Q2 EPS (69c), consensus (76c)
18d ago
QURE
QURE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
QURE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
20d ago
QURE
uniQure Shareholders Approve Key Proposals at Annual Meeting
PremiumCompany Announcements
uniQure Shareholders Approve Key Proposals at Annual Meeting
2M ago
8K
QURE
uniQure appoints Kylie O’Keefe as chief customer, strategy officer
PremiumThe Fly
uniQure appoints Kylie O’Keefe as chief customer, strategy officer
2M ago
QURE
Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint
PremiumThe Fly
Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint
2M ago
CLPT
QURE
Positive Outlook for uniQure’s AMT-130 Program Drives Buy Rating Amid Regulatory Advancements and Robust Clinical Framework
PremiumRatingsPositive Outlook for uniQure’s AMT-130 Program Drives Buy Rating Amid Regulatory Advancements and Robust Clinical Framework
2M ago
QURE
Buy Rating for uniQure Driven by Promising AMT-130 Advancements and Strategic FDA Alignment
Premium
Ratings
Buy Rating for uniQure Driven by Promising AMT-130 Advancements and Strategic FDA Alignment
2M ago
QURE
RBC Capital views FDA flexibility on another HD drug as positive for PTC’s ‘518
Premium
The Fly
RBC Capital views FDA flexibility on another HD drug as positive for PTC’s ‘518
2M ago
PTCT
QURE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >